Alcohol consumption and the risk of liver disease: a nationwide, population-based study
Open Access
- 28 November 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1290266
Abstract
Introduction: Although most patients with alcohol-related liver disease (ALD) have a history of prolonged and heavy drinking, there is no clear threshold defining the level of alcohol consumption that leads to ALD. We aimed to evaluate the correlation between average alcohol consumption and the risk of liver disease and to determine the threshold for clinically significant alcohol consumption.Materials and methods: Using the Korean National Health Insurance database, we identified participants who underwent a health-screening program in 2010 and 2011 and retrospectively analyzed their data until 2019. To diagnose and categorize the extracted participants, we used the International Classification of Diseases version 10 and Fatty Liver Index. The primary outcome was to determine the incidence of newly diagnosed liver-related diseases during the observation period and compare the incidence of liver-related diseases among non-drinkers and drinkers based on the amount of alcohol consumption.Results: A total of 53,006 patients were enrolled and followed-up for a median of 8.4 years, during which 1,509 cases of liver-related diseases occurred. The participants were divided into five groups: no alcohol consumption (n = 31,359), 1st quartile (n = 5,242), 2nd quartile (n = 5,704), 3rd quartile (n = 5,337), and 4th quartile (n = 5,364). The corresponding number of glasses of alcohol consumed per week for each quantile (Q1, Q2, Q3, and Q4) was labeled 2.5 ± 1.1 standard units (1 standard unit = 8 g alcohol), 5.4 ± 1.9 standard units, 11.5 ± 3.3 standard units, and 27.9 ± 18.2 standard units, respectively. Compared with non-drinkers, the risk of liver-related disease was found to be higher in Q1 drinkers (adjusted hazard ratio [aHR], 1.09; 95% CI, 0.90–1.33), Q2 drinkers (aHR, 1. 10; 95% CI, 0.91–1.32), Q3 drinkers (aHR, 1.33; 95% CI, 1.11–1.59), and Q4 drinkers (aHR, 1.47; 95% CI, 1.24–1.75).Conclusion: We report that our study has shown that drinking more than 11.5 ± 3.3 standard units/week (92 ± 26.4 g/week) significantly increases the risk of developing liver-related diseases. Therefore, as a preventive measure to reduce the risk of developing liver disease, alcohol consumption should be limited beyond traditionally recommended levels.Keywords
This publication has 40 references indexed in Scilit:
- Alcohol consumption and risk of coronary artery disease: A dose-response meta-analysis of prospective studiesNutrition, 2016
- Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative dataBMC Gastroenterology, 2015
- Alcohol Consumption and Risk Of Heart Failure: A Dose–Response Meta-Analysis of Prospective StudiesEuropean Journal of Heart Failure, 2015
- Underreporting in Alcohol Surveys: Whose Drinking Is Underestimated?Journal of Studies on Alcohol and Drugs, 2015
- Alcohol-related dementia: an update of the evidenceAlzheimer's Research & Therapy, 2013
- Alcoholism and Diabetes MellitusDiabetes & Metabolism Journal, 2012
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- The positive and negative health effects of alcohol‐ and the public health implicationsJournal of Internal Medicine, 2009
- Alcohol Consumption and the Risk of Hypertension in Women and MenHypertension, 2008
- Pathophysiology of alcoholic pancreatitis: An overviewWorld Journal of Gastroenterology, 2006